A number of CCR scientists will present their research at the AACR Annual Meeting in Atlanta, between March 29 - April 3, 2019. Selected oral presentations are listed below. A full list of abstracts can be found on the AACR website.
Saturday, March 30, 2019
| Time | Title | Authors | Session |
|---|---|---|---|
| 10:15 AM - 10:40 AM | Neutrophil adaptation to the cancer niche | Daniel McVicar | ED26 - Diverse Functions of Neutrophils in Cancer |
Sunday, March 31, 2019
| Time | Title | Authors | Session |
|---|---|---|---|
| 2:00 PM - 2:05 PM | HTAN program overview | Philipp Oberdoerffer | NIH03 - Towards the Generation of Spatial Human Tumor Maps |
Monday, April 1, 2019
| Time | Title | Authors | Session |
|---|---|---|---|
| 11:30 AM - 11:50 AM | Training opportunities in NCI Intramural Programs | Jonathan Wiest | NIH06 - NCI-Sponsored Training Awards and Opportunities |
| 11:05 AM - 11:30 AM | The microbiome in cancer therapy | Giorgio Trinchieri | SY14 - The Microbiome as an Orchestrator of Immunity and Cancer Immunotherapy |
| 11:39 AM - 12:02 PM | Phase I evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus (HPV)-associated malignancies | Julius Strauss | CTPL03 - Optimizing PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy: Dedicated to the Memory of Waun Ki Hong |
| 1:30 PM - 1:50 PM | SY45-02 - Harnessing genetic interactions to advance whole-exome precision cancer treatment | Eytan Ruppin | SY45-313 - The Next Generation of Precision Cancer Medicine: Recognizing and Exploiting the Complexity |
| 1:30 PM - 1:55 PM | The evolution of CAR-T cell based immunotherapy in hematologic malignancies | Nirali Shah | AOS02 - Emerging Immunotherapies for Childhood Cancer |
| 1:45 PM - 2:00 PM | MyPART: Engaging rare tumor patients and their families in rare tumor research | Karlyne Reilly | NIH08 - New NCI Collaborative Initiatives on Rare Tumors and RASopathies |
| 2:00 PM - 2:15 PM | RASopathies: Natural history study and plans for interventional clinical trials | Marielle Yohe | NIH08 - New NCI Collaborative Initiatives on Rare Tumors and RASopathies |
| 1:50 PM - 2:10 PM | Strategies to overcome resistance to targeted therapy of lymphoma based on functional genomic and chemical screens | Louis Staudt | SY42 - Dharma Master Jiantai Symposium in Targeted Therapy: Systematic Elucidation of Nononcogene Targets |
| 6:15 PM - 6:30 PM | From first-in-human to FDA approval in 4 years: The power of partnering with the NCI | James Gulley | NIH10 - NCI Innovations as a Key Driver of New Company Formation and Early-Stage Technologies |
| 6:15 PM - 6:45 PM | Harnessing immune plasticity in the metastatic niche | Rosandra Natasha Kaplan | SS01 - Joint Cancer Immunology (CIMM) / Tumor Microenvironment (TME) Working Groups Evening Scientific Session |
Tuesday, April 2, 2019
| Time | Title | Authors | Session |
|---|---|---|---|
| 8:25 AM - 8:50 AM | T-cell therapy targeting unique cancer mutations | Steven Rosenberg | PL03 - Manipulating the Immune System in Cancer Therapy |
| 2:00 PM - 2:25 PM | Targeting the genetic and metabolic basis of renal cell carcinoma | Marston Linehan | AOS07 - Genitourinary, Bladder, and Renal Cancers |
| 3:20 PM - 3:35 PM | HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction | Natasha Caplen | MS.MCB04.01 - Deregulated Transcription and RNA Processing in Cancer |
| 7:17 PM - 7:25 PM | Interferon signaling contributes to prostate cancer self-renewal and therapy resistance | Supreet Agarwal | TM04 - Tumor Microenvironment Working Group (TME) Town Hall Meeting and Networking Reception |